MBX-2982   Click here for help

GtoPdb Ligand ID: 10166

Synonyms: MBX2982
PDB Ligand
Compound class: Synthetic organic
Comment: MBX-2982 is a GPR119 agonist [1], that is a functional activator of human glucokinase activity in vitro [2].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 0
Rotatable bonds 7
Topological polar surface area 122.46
Molecular weight 448.18
XLogP 3.63
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CCc1cnc(nc1)N1CCC(CC1)c1scc(n1)COc1ccc(cc1)n1cnnn1
Isomeric SMILES CCc1cnc(nc1)N1CCC(CC1)c1scc(n1)COc1ccc(cc1)n1cnnn1
InChI InChI=1S/C22H24N8OS/c1-2-16-11-23-22(24-12-16)29-9-7-17(8-10-29)21-26-18(14-32-21)13-31-20-5-3-19(4-6-20)30-15-25-27-28-30/h3-6,11-12,14-15,17H,2,7-10,13H2,1H3
InChI Key NFTMKHWBOINJGM-UHFFFAOYSA-N
No information available.
Summary of Clinical Use Click here for help
Development of MBX-2982 as an anti-hyperglycemic monotherapy as a treatment for type 2 diabetes was discontinued following Phase 2 evaluation (see NCT01035879 for clinical trial details).
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT01035879 Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of MBX-2982 Administered Daily for 4 Weeks as Monotherapy in Patients With Type 2 Diabetes Phase 2 Interventional CymaBay Therapeutics, Inc.